Trending Health

Listen as Radio

Non-smoking lung cancer patients struggle with treatment effectiveness

Non-smokers with non-small cell lung cancer (NSCLC) may be resistant to standard treatments due to a combination of genetic mutations, according to researchers from University College London, the Francis Crick Institute, and AstraZeneca. The study, published in _Nature Communications_, found that a mutation in the EGFR gene combined with a mutation in the p53 gene led to the development of drug-resistant tumors in non-smokers with NSCLC. Patients with both mutations had poorer survival rates, with some tumors growing after treatment. Researchers are now working on developing a diagnostic test to detect this dangerous genome doubling and exploring combination therapies to address treatment-resistant cases. Dr. Shuresh Ramalingam of the Winship Cancer Institute highlighted the importance of tailored therapies for NSCLC cases where standard treatments fail, particularly in individuals who have never smoked, a demographic that has seen an increase in lung cancer cases in recent years. sources

Jun 14 2024, 5 am

Lifestyle changes delay diabetes, lower heart disease and death risk

A recent study conducted by researchers in China has found that delaying the onset of type 2 diabetes by at least four years can significantly reduce the risk of cardiovascular disease and mortality. The study, which analyzed data from the Da Qing Diabetes Prevention Study, followed 540 participants with prediabetes for over 30 years. Participants who avoided developing type 2 diabetes for four years had lower rates of cardiovascular disease and all-cause mortality. These findings highlight the importance of preventive measures and lifestyle changes in managing prediabetes and reducing the risk of complications associated with type 2 diabetes. Experts emphasize the significance of early intervention and maintaining healthy habits to prevent the development of diabetes and its related health issues. sources

Jul 15 2024, 5 pm

Semaglutide and low-calorie diet optimal for type 2 diabetes

A recent study suggests that combining the drug semaglutide with a very low-calorie diet may be an effective way to manage type 2 diabetes. The combination treatment showed improvements in pancreatic beta cell function, which produce insulin. While a very low-calorie diet alone led to more weight loss than semaglutide, the combination of both resulted in the best outcomes. However, maintaining a very low-calorie diet long-term may be challenging. Experts caution that sustainable results may require addressing factors like stress and sleep, in addition to medication. The study's findings highlight the potential for this approach in diabetes management, but further research is needed to understand its long-term effectiveness. sources

Jul 14 2024, 11 am

New drug cuts rebound headaches by preventing migraines

A new study has found that the drug atogepant, used for migraine prevention, can also significantly reduce rebound headaches in individuals with chronic migraines. Led by headache specialist Peter J. Goadsby, the study involved 755 participants who experienced chronic migraines and overused pain medications. Participants taking atogepant had fewer migraine days and a reduced need for painkillers. The drug relaxes blood vessels, preventing migraines from becoming too severe. Rebound headaches occur when medication wears off, causing the headache to return. Overuse of pain medications can lead to medication overuse headaches, emphasizing the importance of preventive measures like atogepant. This research highlights the potential of atogepant in managing chronic migraines effectively and reducing the frequency of rebound headaches. sources

Jul 13 2024, 2 pm

Ozempic and similar drugs may reduce risk of 10 cancers

A recent study published in JAMA Network Open suggests that certain type 2 diabetes medications, specifically glucagon-like peptide receptor agonists (GLP-1RAs) like Ozempic, may reduce the risk of 10 obesity-related cancers. The study, which compared different diabetes treatment approaches, found that participants on GLP-1RAs had a significantly lower risk for various cancers compared to those on insulin. However, the study has some limitations, including potential errors in diagnosis and lack of control over variables after participants' first prescription. Experts caution that while GLP-1RAs may help lower cancer risks, it is essential to consider factors like weight loss, exercise, and nutrition in cancer prevention. Further research is needed to fully understand the potential benefits and risks of GLP-1RAs in reducing cancer risk. sources

Jul 12 2024, 7 pm

Heavy metals found in tampons: What you need to know

A recent study by researchers at the UC Berkeley School of Public Health has revealed the presence of 16 different heavy metals in tampons from 14 different brands purchased in the U.S. and the U.K., including arsenic and lead. With over 100 million cisgender women worldwide using tampons during their menstrual cycle, concerns have been raised about the potential health risks associated with these toxic heavy metals. While tampons are generally considered safe, improper use or prolonged wear can increase the risk of toxic shock syndrome. The study found that both organic and non-organic tampons contained heavy metals, urging consumers to be cautious when selecting menstrual products and encouraging further research into safer alternatives. Experts emphasize the importance of transparency from manufacturers and the need for more research to determine safe levels of metals in tampons to protect women's health. sources

Jul 12 2024, 8 pm

New method erases 'bad memory' response in Parkinson's treatment

Researchers at the University of Alabama in Birmingham have made a significant breakthrough in the treatment of dyskinesia, a debilitating side effect of long-term Parkinson's therapy. By targeting dyskinesia as a "bad motor memory" and inhibiting the protein Activin A, they were able to prevent the development of uncontrollable movements in mouse models. This innovative approach could potentially enhance the effectiveness of current Parkinson's treatments and greatly improve the quality of life for patients. The study, published in The Journal of Neuroscience, sheds light on the challenges posed by common treatments for Parkinson's disease, such as L-DOPA, which can lead to dyskinesia over time. The researchers' findings offer hope for a new strategy to prevent dyskinesia and extend the duration of Parkinson's treatment, ultimately aiming to enhance patient care and satisfaction. sources

Jul 11 2024, 11 pm

Researchers predict Alzheimer's stages in individuals with new method

A team of researchers from Amsterdam University Medical Center has developed a model that can predict cognitive decline in individuals with mild cognitive impairment or mild dementia due to Alzheimer's disease. The study, published in Neurology, aims to personalize treatments and forecasts for patients, potentially leading to better care for those affected by the disease. The model utilizes data from the Amsterdam Dementia Cohort and includes information from MRI scans and biomarkers to predict cognitive decline over time. While the model shows promise in providing valuable information to clinicians and patients, experts emphasize the uncertainty in predicting individual trajectories. Despite this, the development of such predictive tools marks a significant step forward in understanding and managing Alzheimer's disease. sources

Jul 11 2024, 6 pm

Study: Tirzepatide more effective for weight loss than semaglutide

A recent study compared the effectiveness of weight loss medications tirzepatide and semaglutide, both used for type 2 diabetes. The research found that tirzepatide was more effective in helping individuals with obesity or overweight lose weight compared to semaglutide. About 82% of participants on tirzepatide experienced a 5% or greater weight loss, while only 66.5% of those on semaglutide achieved the same. However, the study had limitations, including a lack of diversity among participants and potential biases in data collection. Researchers noted the need for further research on these medications, including their long-term effects and equitable access. Experts recommend consulting healthcare providers to determine the best weight loss medication based on individual needs and insurance coverage. sources

Jul 10 2024, 10 pm

Which Macronutrient Triggers Most Insulin Release?

A recent study published in _Cell Metabolism_ has revealed that different macronutrients, such as carbohydrates, proteins, and fats, may trigger varying insulin responses in individuals. While carbohydrates have long been known to prompt insulin release more than other nutrients, this research suggests that some people may have larger reactions to proteins or fats. The study, which examined insulin responses in pancreatic islets from deceased human donors with and without type 2 diabetes, found that some islets exhibited stronger responses to proteins or fats than to carbohydrates. Although the findings may not directly translate to living humans, experts believe that further clinical research could lead to personalized nutrition strategies for better blood sugar management, ultimately improving overall health outcomes. The study's authors hope that their research will inspire larger and more diverse clinical studies to enhance the applicability of their results to real-world settings. sources

Jul 09 2024, 11 pm

Aging livers rejuvenated in successful preclinical study

A recent study has shown promising results in reversing age-related liver damage in mice and human cell cultures, focusing on a process called ferroptosis that affects key liver cells. Researchers found that genetic clusters associated with this process were present in both mice and human cells, suggesting a potential target for pharmaceutical interventions. The study, published in _Nature Aging_, demonstrated that liver cells in older mice receiving a specific drug appeared young and healthy. This research offers hope for developing therapies for nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD), which can lead to organ failure. While there are no direct treatments for NAFLD/ MASLD, maintaining a healthy diet and weight may help slow its progression. sources

Jul 09 2024, 12 am

For the fastest, latest, not so wokest news, 'experts say' you need to visit Eznews

End of news stories. Come back in an hour!